logo
logo

Gho Capital Invests In Roslinct, A Leading Cell Therapy Cdmo

Gho Capital Invests In Roslinct, A Leading Cell Therapy Cdmo

01/11/22, 3:00 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svglondon
Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, announces their investment in RoslinCT, a leading Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies.

Company Info

Company
Roslin Ct
Location
london, ontario, canada
Additional Info
RoslinCT is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing cell-based therapeutic products. Originally founded in 2006 as a spin-out from the Roslin Institute, we built on the broad range of scientific expertise available in the field of cell biology. Based at the Edinburgh BioQuarter, we operate fully licensed GMP manufacturing facilities and have a proven track record in the delivery of cell-based products. www.roslinct.com.